Correlations of Bcl-2 Expression with Clinicopathological Features in Breast Cancer

Yonsei Medical Journal

Volumn 38, Issue 4, 1997, Pages 206-211

  Lee, Hy De ^a,b   Koo, Ja Yun ^a   Jung, Woo Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

bcl 2 protooncogene; Breast cancer

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BCL 2;

ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0031204927     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1997.38.4.206     Document Type: Article

References (20)

1. Bhargava V, Kell DI, Rijn MVD, Earnke RA : bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145: 535-540, 1994
2. Bloom HJG, Richardson WW : Histological grading and prognosis in breast cancer. Br J Cancer 11: 358-377, 1957
3. Boise LM, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thpmpson CB: bcl-x bcl2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993
4. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R : Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am J Pathol 143: 390-400, 1993
5. Doglioni C, Dei TAP, Laurino L, Chiarelli C, Barreschi M, Viale G: The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with reference to oestrogen receptor status. Virchows Arch 424: 47-51, 1994
6. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM : Downregulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54: 2095-2097, 1994
7. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
8. Hockenbery DM: The bcl-2 oncogene and apoptosis. Semin Immunol 4: 413-420, 1992
9. Joensuu H, Pylkkanen L, Toikkanen S: bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145: 1191-1198, 1994
10. Korsmayer SJ: bcl-2: an antidote to programmed cell death. Cancer Surv 15: 105-118, 1992
11. L, and tamoxifen induced apoptosis in human MCF-7 breast cancer cells. Clin Cancer Res 2: 1215-1219, 1996
12. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 69: 135-139, 1994
13. Lu QL, Elia E, Lucas S, Thomas JA: bcl-2 proto-oncogene expression in Epstein-Barr virus associated nasopharyngeal carcinoma. Int J Cancer 53: 29-35, 1993
14. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J: bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 129: 1363-1378, 1995
15. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell PC: Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236: 1295-1299, 1987
16. Silvestrini R, Benini E, Veronesi S, Daidone MG, Tomasic G, Squicciarini P, Salvadori B: p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. J Clin Oncol 14: 1604-1610, 1996
17. Silvestrini R, Veroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, DiFronzo G, Rilke F, Veronesi U: The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. J Natl Cancer Inst 86: 499-504, 1994
18. Teixeira C, Reed JC, Christine PMA: Estrogen promoted chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902-3907, 1995
19. Tsujimoto Y, Finger IR, Yunis J: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14,18) chromosome translocation. Science 226: 1097-1099, 1984
20. Yunis IJ, Oken MM, Kaplan ME, Endsrud KM, Howe RR, Theologides A: Cloning of the chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 307: 1231-1236, 1982